Literature DB >> 8743281

Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue.

R Bonacci1, A Pinchera, P Fierabracci, A Gigliotti, L Grasso, C Giani.   

Abstract

Several authors have demonstrated the presence of estrogen receptors (ER) and progesterone receptors (PR) in thyroid tissue, generally using dextran coated charcoal method (DCCA). The aim of the study was to measure ER and PR in thyroid specimens using an immunoenzymatic method, and to evaluate the meaning of different prevalence of ER and PR in malignant and benign thyroid disease, as compared with normal thyroid tissue. We have measured ER and PR in thyroid tissue from 28 benign and 20 malignant thyroid lesions, and in 38 samples of surrounding normal thyroid tissues. The sensitivity of ER-EIA and PR-EIA was 1.0 and 1.5 fmol/mg protein, respectively. In thyroid carcinoma the frequency of ER positivity (ER+) was 7/20 (35%); it was significantly higher in the surrounding normal tissue (15/20; 71%) (p = 0.03). In benign thyroid disease, the prevalence of ER+ was 11/28 (39%) and in the surrounding normal tissue it was 11/18 (61%) (p = not significant). PR+ was detected in 7/20 (35%) thyroid cancers and in 15/28 (53%) benign lesions without significant difference with the frequency detected in the surrounding normal tissues. ER and PR concentrations (mean +/- SD) in thyroid cancer was 2.2 +/- 2.2 and 2.2 +/- 2.9 respectively, similarly to that detected in benign thyroid disease and in normal tissue. The simultaneous presence of ER and PR (ER+PR+) was also evaluated. We have found that the frequency of ER+ PR+ was significantly higher in benign lesions (8/28; 28.6%) as compared with malignant samples (1/20; 5%) (p < 0.05); the frequency of ER+PR+ was significantly higher in normal tissue surrounding the malignant lesions (9/20; 45) (p = 0.003). Our data indicate i) EIA method is appropriate to detect ER and PR in thyroid tissue. ii) The frequency of ER+ and ER+PR+ specimens is significantly higher in normal thyroid tissue than in pathologic tissues. This indicates that ER and PR immunoassays may be useful tools to evaluate the normal biological activity of thyroid cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743281     DOI: 10.1007/BF03349859

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

Review 1.  Breast cancer (3).

Authors:  J R Harris; M E Lippman; U Veronesi; W Willett
Journal:  N Engl J Med       Date:  1992-08-13       Impact factor: 91.245

2.  Estrogen and estrogen receptors in thyroid carcinomas.

Authors:  Y Mizukami; T Michigishi; A Nonomura; T Hashimoto; M Noguchi; F Matsubara
Journal:  J Surg Oncol       Date:  1991-07       Impact factor: 3.454

3.  Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.

Authors:  G Leclercq; H Bojar; J Goussard; R I Nicholson; M F Pichon; A Piffanelli; A Pousette; S Thorpe; M Lonsdorfer
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

4.  Distribution and characterization of steroid hormone receptors in human thyroid tissue.

Authors:  P K Chaudhuri; N Patel; L Sandberg; R A Prinz
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

5.  Estrogen and thyroid-stimulating hormone (TSH) receptors in neoplastic and nonneoplastic human thyroid tissue.

Authors:  O H Clark; P L Gerend; M Davis; P E Goretzki; P G Hoffman
Journal:  J Surg Res       Date:  1985-02       Impact factor: 2.192

6.  Thyroid and steroid receptors.

Authors:  M Marugo; G Torre; D Bernasconi; L Fazzuoli; S Berta; G Giordano
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

7.  Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.

Authors:  V C Jordan; H I Jacobson; E J Keenan
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

8.  Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.

Authors:  N M Diaz; G Mazoujian; M R Wick
Journal:  Arch Pathol Lab Med       Date:  1991-12       Impact factor: 5.534

9.  Estrogen and progesterone receptor content in human thyroid disease.

Authors:  K H van Hoeven; C J Menendez-Botet; E W Strong; A G Huvos
Journal:  Am J Clin Pathol       Date:  1993-02       Impact factor: 2.493

Review 10.  Progesterone receptors and human breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

View more
  6 in total

1.  High prevalence of breast cancer in patients with benign thyroid diseases.

Authors:  I Muller; A Pinchera; E Fiore; V Belardi; V Rosellini; E Giustarini; C Giani
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

2.  ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.

Authors:  Flavia Magri; Valentina Capelli; Margherita Gaiti; Laura Villani; Francesca Zerbini; Luigi La Manna; Mario Rotondi; Luca Chiovato
Journal:  Endocrine       Date:  2014-10-22       Impact factor: 3.633

3.  The impact of age and gender on papillary thyroid cancer survival.

Authors:  J Jonklaas; G Nogueras-Gonzalez; M Munsell; D Litofsky; K B Ain; S T Bigos; J D Brierley; D S Cooper; B R Haugen; P W Ladenson; J Magner; J Robbins; D S Ross; M C Skarulis; D L Steward; H R Maxon; S I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-10       Impact factor: 5.958

4.  High concentration of estradiol has a negative correlation with free thyroxine during the second trimester of pregnancy.

Authors:  Leqi He; Xiaoying Li; Zaoping Chen; Wei Wang; Kai Wang; Xinmei Huang; Qian Yang; Wencai Ke; Jun Liu; Bingbing Zha
Journal:  Endocr Connect       Date:  2022-09-26       Impact factor: 3.221

5.  Role of estrogen in thyroid function and growth regulation.

Authors:  Ana Paula Santin; Tania Weber Furlanetto
Journal:  J Thyroid Res       Date:  2011-05-04

6.  Progesterone Upregulates Gene Expression in Normal Human Thyroid Follicular Cells.

Authors:  Ana Paula Santin Bertoni; Ilma Simoni Brum; Ana Caroline Hillebrand; Tania Weber Furlanetto
Journal:  Int J Endocrinol       Date:  2015-05-21       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.